PAR-25-059-Full-Announcement.html

This document is a Funding Opportunity Announcement (FOA) for the Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) grant program, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) from the Department of Health and Human Services National Institutes of Health.

The FOA encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. The program aims to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs. Eligible applicant types include public or Indian housing authorities, independent school districts, small businesses, tribal organizations, higher education institutions, non-501(c)(3) nonprofits, special district governments, county governments, tribal governments, city/township governments, state governments, for-profit organizations, and 501(c)(3) nonprofits. The application deadline and award details are not provided in this document.